Risk/benefit analysis for the use and approval of thrombolytic, antiarrhythmic, and hypolipidemic agents
Subtitle: proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
By: edited by Joel Morganroth and E. Neil Moore.
Contributors: Morganroth, Joel.; Moore, E. Neil.
Series: Developments in cardiovascular medicine ;; 100; Developments in cardiovascular medicine ;; v. 100.
Publisher: Kluwer Academic Publishers
Published: 1989
Place of publication: Boston
Language: eng
Number of pages: 301
Subjects: Fibrinolytic agents -- Effectiveness -- Congresses.; Myocardial depressants -- Effectiveness -- Congresses.; Antilipemic agents -- Effectiveness -- Congresses.; Risk assessment -- Congresses.; Anti-Arrhythmia Agents -- therapeutic use -- congresses.; Antilipemic Agents -- therapeutic use -- congresses.; Fibrinolytic Agents -- therapeutic use -- congresses.
Notes: Includes bibliographical references.